🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

69 results for “NAC” Clear

  1. nonacog beta pegol

    REFIXIA

    EMA: approved · PMDA: approved

    B02BD04

  2. nonacog gamma

    RIXUBIS

    EMA: approved

    B02BD04

  3. pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)

    HUMENZA

    EMA: withdrawn

    J07BB02

  4. pandemic influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    AREPANRIX

    EMA: withdrawn

    J07BB02

  5. pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)

    EMA: approved

    J07BB02

  6. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    FOCLIVIA

    EMA: approved

    J07BB02

  7. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    INCELLIPAN

    EMA: approved

    J07BB02

  8. pandemic influenza vaccine (h5n1) (whole virion, inactivated, prepared in cell culture)

    PANDEMIC INFLUENZA VACCINE H5N1 BAXTER AG

    EMA: withdrawn

    J07BB01

  9. pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

    DARONRIX

    EMA: unknown

    J07BB01

  10. phenacemide

    PHENURONE

    ORAL FDA: approved

  11. pinacidil

    PINDAC

    ORAL FDA: approved

  12. prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    PREPANDRIX

    EMA: withdrawn

    J07BB02

  13. prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS

    EMA: unknown

    J07BB02

  14. prepandemic influenza vaccine (h5n1) (whole virion, inactivated,prepared in cell culture)

    VEPACEL

    EMA: withdrawn

    J07BB01

  15. revefenacin

    REVEFENACIN

    INHALATION FDA: approved · NMPA: clinical trials

  16. rilonacept

    RILONACEPT FGK REPRESENTATIVE SERVICE GMBH Regeneron UK Limited

    SINGLE-USE FDA: approved · EMA: application withdrawn

    L04AC04

  17. solifenacin succinate

    SOLIFENACIN SUCCINATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  18. trenonacog alfa

    IXINITY

    EMA: application withdrawn

    B02BD12

  19. zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    AFLUNOV

    EMA: approved

    J07BB02

  20. zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    CELLDEMIC

    EMA: approved

    J07BB02

  21. zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)

    ZOONOTIC INFLUENZA VACCINE SEQIRUS

    EMA: approved

    J07BB02

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources